Did Inbreeding Royals Evolve?

A new study suggests that in the Spanish Habsburg royal family, natural selection may have diminished the most harmful effects of inbreeding.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Charles II of Spain (1661-1700), who was infertileSCHLOSS ROHRAUThe Habsburg royal family of Spain, which favored inbred marriages to keep titles in the family and forge alliances, may have evolved from 1450–1800 to blunt the worst effects of inbreeding, according to a study published this month in Heredity. But some geneticists are not convinced, reported Nature.

Evolutionary theory predicts that over time, there will be a purging of the harmful mutations that result from inbreeding. But while the effect has been observed in animals and plants, there is little evidence for this phenomenon in human populations. Researchers from the University of Santiago de Compostela in Spain decided to look for that evidence by analyzing 350 years of genealogical records of the Spanish Hapsburgs, a family with a long history of inbreeding.

Inbreeding increases the probability that offspring will inherit two copies of a recessive disease-causing mutation, but infertility—which may be a consequence of inbreeding—can block such mutations from being passed down. Assuming that early deaths—in infancy, excluding miscarriages and stillbirths, and early childhood, up to the age of 10—were a result ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies